Current role
Nadia Waheed, M.D.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Nadia Waheed, M.D.
Ocular Therapeutix, Inc reported in an 8-K filed April 18, 2024 that Nadia Waheed, M.D. was appointed Chief Medical Officer, effective May 20, 2024.
“On April 16, 2024, the Company announced that Nadia Waheed, M.D., had been appointed to serve as Chief Medical Officer of the Company, effective upon the anticipated commencement of her employment with the Company on May 20, 2024.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Ocular Therapeutix, Inc (OCUL)
SEC 8-K
Current2024-05-20–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Ocular Therapeutix, Inc
Other people whose current roles at this company are on record from its filings.
- Pravin Dugel CEO
- Pravin U. Dugel CEO, Chairman, Board Member
- Pravin U. Dugel, M.D. CEO, Chairman
- Charles Warden Chairman, Board Member
- Jason Robins CFO
- Donald Notman COO
- Philip C. Strassburger General Counsel
- Adrienne L. Graves Board Member
- Adrienne L. Graves, Ph.D. Board Member
- Jeffrey Heier Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.